Amgen reports results of Phase 2 MariTide obesity study

European Medicines Agency recommends approval of Alvotech's biosimilar to Eylea

Gan & Lee presents trial results for novel diabetes therapies at ADA's 85th Scientific Sessions

TME Pharma and SERI partner to advance NOX-E36 in ophthalmology through option framework agreement

Innovent reports first participant dosed in new Phase 3 trial of mazdutide in China

Eluminex Biosciences announces EB-105 Phase 1b single ascending dose study results in patients with diabetic macular edema

Vivoryon Therapeutics presents positive meta-analysis data for varoglutamstat

Camurus and Lilly agree licensing deal for FluidCrystal incretins

Genprex signs new research agreement with University of Pittsburgh to advance diabetes gene therapy

Innovent reports first patient dosed in efdamrofusp alfa (IBI302) Phase 2 study in diabetic macular edema

Beijing Tide's AT2R antagonist TRD205 advances to Phase II trial in chronic post-surgical neuropathic pain

FDA accepts Novo Nordisk's filing application for oral semaglutide 25 mg

Genprex enters into exclusive patent license agreement with NYU Langone Health to advance mesothelioma gene therapy

Diamyd Medical to receive European patent for insulin antigen treatment targeting autoimmune diabetes

Renalytix reports real-world impact of KidneyIntelX on targeted kidney disease treatment